As a matter of fact, previous studies performed in humans [64,65] and mice [66] have connected the effects of increased APOC1 in combined hyperlipidaemia with a more pronounced impact on circulating triglycerides [67,68]. The gene discussed is APOC1; the disease is hyperlipidemia.